期刊文献+

双时相^(18)F-FDG PET显像用于肿瘤良恶性鉴别诊断 被引量:3

Dual phase ^(18)F-FDG PET imaging in the differential diagnosis of malignant and benign lesions
下载PDF
导出
摘要 目的探讨双时相^(18)F-FDG PET 显像在肿瘤良恶性鉴别中的临床价值。方法 52例单次显像难以鉴别病变性质的患者行双时相全身^(18)F-FDG PET/CT 显像,将显像结果与病理学检查结果对照。结果 43例延迟显像 SUV 升高的患者中有39例经病理检查证实为恶性病变,4例为良性病变;9例延迟显像 SUV 降低的患者中有7例经病理检查证实为良性病变,2例为恶性病变。灵敏度为95.1%,准确性为88.5%,特异性为63.6%,阳性预测值为90.7%,阴性预测值为7/9例。结论双时相^(18)F-FDG PET 对良恶性病变的鉴别具有较高的灵敏度和准确性。 Objective It was realized that static PET imaging might not be accurate at fixed time point after ^18 F-FDG administration. The dual phase ^18 F-FDG PET was employed in this study in order to differentiate malignant from benign lesions. Methods Fifty-two patients with difficulty in interpreting the nature of their lesions at routine imaging underwent delayed whole body ^18F-FDG PET at 2 h post-injection. Visual inspection of PET images and SUV compared with pathological finding were used for evaluation. Results Of 43 cases with increased SUV in delay imaging, 39 were confirmed/nalignant and 4 benign. And 7 of 9 cases with decreased SUV were confirmed benign and 2 malignant. The dual phase PET imaging in this group of patients had sensitivity of 95.1%, specificity 63.6%, accuracy 88.5%, positive predictive value 90.7%, and negative predictive value 7/9. Conclusion In differentiating malignant from benign lesions, dual phase PET was more accurate than single static imaging.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第4期227-229,共3页 Chinese Journal of Nuclear Medicine
关键词 肿瘤 诊断 鉴别 体层摄影术 发射型计算机 脱氧葡萄糖 Neoplasms Diagnosis, differential Tomography, emission-computed Deoxyglucose
  • 相关文献

参考文献11

  • 1Lowe VJ, Fletcher JW, Gotar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol, 1998, 16: 1075-1084.
  • 2Sugawara Y, Braun D, Kison P, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med, 1998, 25: 1238-1243.
  • 3Torizuka T, Zasadny KR, Recker B, et al. Untreated primary lung and breast cancer: correlation between ^18F-FDG kinetic rate constants and finding of in vitro studies. Radiology, 1998, 207 : 764- 774.
  • 4Huang SC. Anotomy of SUV. Nucl Med Biol, 2000, 27: 643-646.
  • 5Hustinx R, Smith RJ, Benard F, et al. Can the standardized uptake value characterize primary brain tumors on FDG PET? Eur J Nucl Med, 1999, 26: 1501-1509.
  • 6Zhuang HM, Duarte PS, Pourdehnad M, et al. A standardized uptake value as an unreliable index of renal disease on FDG PET imaging. Clin Nucl Med, 2000, 25: 358-360.
  • 7Matthies A, Hickeson M, Cuchiara A, et al. Dual time point ^18FFDG PET for the evaluation of pulmonary nodules. J Nucl Med, 2002, 43 : 871-875.
  • 8赵军,林祥通,管一晖,左传涛,华逢春,陆舜.结核病^(18)F-FDG PET图像表现的多样性[J].中华核医学杂志,2003,23(S1):41-43. 被引量:44
  • 9Hickeson M, Zhuang HM, Chacko T, et al. Superiority of dual versus single time point FDG PET imaging in the assessment of pulmonary nodules (Abstract). J Nucl Med, 2002, 43 Suppl: 155.
  • 10赵军,林祥通,管一晖,左传涛,华逢春.双时相PET显像在肺良恶性病变鉴别诊断中的应用[J].中华核医学杂志,2003,23(1):8-10. 被引量:63

二级参考文献14

共引文献102

同被引文献20

  • 1姚稚明,屈婉莹,刘甫庚,韩丽君,于治国,李伟,赵波沣,朱明,张建飞.^(18)F-FDG PET/CT双时相显像对孤立性肺结节的诊断价值[J].中华核医学杂志,2007,27(1):5-7. 被引量:22
  • 2de Beukelaar JW,Sillevis Smitt PA.Managing paraneoplastic neurological disorders.Oncologist,2006,11:292-305.
  • 3Younes-Mhenni S,Janier MF,Cinotti L,et al.FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.Brain,2004,127:2331-2338.
  • 4Candler PM,Hart PE,Barnett M,et al.A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.J Neurol Neurourg Psychiatry,2004,75:1411-1415.
  • 5Linke R,Schroeder M,Helmberger T,et al.Antibody-positive paraneoplastic neurologic syndromes:value of CT and PET for tumor diagnosis.Neurology,2004,63:282-286.
  • 6Leyhe T,Schüle R,Schw(a)rzler F,et al.Second prinmy tumor in antiMa1/2-positive paraneoplastic limbic encephalitis.J Neurooncol,2006,78:49-51.
  • 7Matthies A,Hickeson M,Cuchiara A,et al.Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.J Nucl Med,2002,43:871-875.
  • 8Patel RR,Subramaniam RM,Mandrekar JN,et al.Occult malignancy in patients with suspected paraneoplastic neurologic syndromes:value of position emission tomography in diagnosis.Mayo Clin Proc,2008,83:917-922.
  • 9Rees JH,Hain SF,Johnson MR,et al.The role of 18F-fluoro-2-deoxyglucose PET scanning in the diagnosis of paraneoplastic neurological disorders.Brain,2001,124:2223-2231.
  • 10Basu S,Alavi A.Role of FDG-PET in the clinical management of paraneoplastic neurlogical syndrome:detection of the underlying malignancy and the brain PET-MRI correlates.Mol Imaging Biol,2008,10:131-137.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部